Association between continuous glucose monitoring and surgical site infection: evidence from critically ill adults
Published
October 3, 2026
Paper ID
PAP-000067
Status
Published
DOI
10.65712/tmj.test000325
Advance Services
Abstract
Background: Practice around continuous glucose monitoring varies widely between centres. Methods: Missing data were handled with multiple imputation. Results: surgical site infection occurred in 17% of the intervention group versus 22% of controls. The adjusted odds ratio was 0.51 (95% CI 0.22 to 0.93). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Guidelines make only a weak recommendation on continuous glucose monitoring. surgical site infection remains a leading cause of avoidable harm among critically ill adults. Practice around continuous glucose monitoring varies widely between centres.
Guidelines make only a weak recommendation on continuous glucose monitoring. The cost of surgical site infection to health systems is substantial.
The cost of surgical site infection to health systems is substantial. Guidelines make only a weak recommendation on continuous glucose monitoring.
Discussion
Future work should test continuous glucose monitoring in a pragmatic multicentre trial.
Residual confounding cannot be excluded. These findings suggest that continuous glucose monitoring is associated with better surgical site infection in critically ill adults. Strengths include the sample size and blinded outcome assessment.
Future work should test continuous glucose monitoring in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Conclusions
Continuous glucose monitoring is a reasonable option for critically ill adults to improve surgical site infection.
References
1. Ahmed L, Kim Z, et al. Vitamin D supplementation and health-related quality of life. Crit Care Med. 2020;257(12):577-1268.
2. Ahmed X, Osei W, et al. Point-of-care ultrasound and post-operative delirium. Lancet. 2021;315(10):5-1758.
3. Rahman C, Ibrahim U, et al. Tranexamic acid and surgical site infection. Lancet. 2008;161(6):97-1531.
4. Farouk W, Ibrahim J, et al. Frailty screening and falls. BMC Med. 2021;260(10):221-1447.
5. Tanaka D, Moreau N, et al. Continuous glucose monitoring and ventilator-free days. N Engl J Med. 2013;129(2):277-1009.
6. Kaur J, Volkov E, et al. An antibiotic stewardship programme and 30-day readmission. BMJ. 2013;83(6):695-1319.
Appendices
Supplementary tables are available on request.
Materials and Methods
Eligible participants were critically ill adults. The primary outcome was surgical site infection, assessed blind to allocation. We conducted a pilot feasibility study across 12 centres between 2018 and 2022.
Missing data were handled with multiple imputation. Eligible participants were critically ill adults. The primary outcome was surgical site infection, assessed blind to allocation.
Analyses were adjusted for age, sex and baseline severity. We conducted a pilot feasibility study across 9 centres between 2017 and 2025.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.
Results
The adjusted odds ratio was 0.68 (95% CI 0.28 to 0.99). Serious adverse events were rare and similar between groups.
3952 participants were included (median age 44 years). surgical site infection occurred in 17% of the intervention group versus 14% of controls. 1086 participants were included (median age 41 years). Effects were consistent across prespecified subgroups.
surgical site infection occurred in 20% of the intervention group versus 18% of controls. Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.57 (95% CI 0.43 to 0.63). surgical site infection occurred in 4% of the intervention group versus 26% of controls.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Male | 366 | 14 | 31.7 | 0.85 | 0.26–1.23 |
| Age ≥ 65 | 484 | 31 | 34.1 | 0.62 | 0.30–1.25 |
| Control | 172 | 106 | 30.4 | 0.48 | 0.53–1.13 |
Values are n (%) unless stated otherwise.

Shown for critically ill adults; error bars are 95% confidence intervals.

Shown for critically ill adults; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.84 (95% CI 0.45 to 0.65). Serious adverse events were rare and similar between groups.
The adjusted odds ratio was 0.42 (95% CI 0.27 to 0.79). The adjusted odds ratio was 0.74 (95% CI 0.41 to 0.93). surgical site infection occurred in 6% of the intervention group versus 35% of controls.